eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in Foxborough, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. eFFECTOR Therapeutics Inc market cap is $941.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. eFFECTOR Therapeutics Inc 52 week high is $0.02 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. eFFECTOR Therapeutics Inc 52 week low is $0.0002 as of November 22, 2026.
eFFECTOR Therapeutics Inc stock price today is $0.0002.
eFFECTOR Therapeutics Inc stock price yesterday was $0.0002.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. eFFECTOR Therapeutics Inc 50-day moving average is $0.0004.